Sponsored By

A legal alternative to CBD: Levagen+® PEA - Infographic

While the cannabis industry is growing, CBD is increasingly being regarded negatively by EFSA and other regulatory agencies. Additionally, the research on CBD and its health benefits is limited. Levagen+®, a clinically researched palmitoylethanolamide (PEA), works on a similar pathway as CBD and is often referred to as the “body’s own CBD”. Levagen+ is accepted as a dietary supplement in the U.S., Europe, Australia and India. View the infographic to learn more about Levagen+.

September 15, 2020

1 Min Read
gencor header image 3
© iStock

Levagen Infographics V10 with CBD Claims  Final

Visit GencorPacific.com to learn more about Levagen+®.

Sponsored by:

Gencor logo

Read more about:

Sponsored ContentInfographic
SUBSCRIBE TO OUR FREE NEWSLETTERS
Get your dose of nutrition science, health ingredient innovations, and nutraceutical R&D!